AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.8 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Gastric Cancer Nanotheranostic Engineering: Gastric Cancer Prewarning and Early Theranostic System

Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument, National Center for Translational Medicine, Collaborative Innovational Center for System Biology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, P. R. China
Show Author Information

References

[1]

R. Siegel, D. Naishadham and A. Jemal, Cancer statistics, 2013. CA Cancer J Clin. 2013, 63: 11-30.

[2]

W.Q. Chen, R.S. Zheng, S.W. Zhang, et al., The incidences and mortalities of major cancers in china, 2010. Chin J Cancer. 2014, 33: 402-405.

[3]

T. Takahashi, Y. Saikawa and Y. Kitagawa, Gastric cancer: Current status of diagnosis and treatment. Cancers (Basel). 2013, 5: 48-63.

[4]

S. Vinogradov, X. Wei, Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (Lond). 2012, 7: 597-615.

[5]

S.H. Kong, D.J. Park, H.J. Lee, et al., Clinicopathologic features of asymptomatic gastric adenocarcinoma patients in Korea. Jap J Clin Oncol, 2004, 34(1): 1-7.

[6]

C. Hamashima, D. Shibuya, H. Yamazaki, et al., The Japanese guidelines for gastric cancer screening. Jap J Clin Oncol, 2008, 38(4): 259-267.

[7]

S. Mizuno, I. Miki, T. Ishida, et al., Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis. Dig Dis Sci, 2010, 55(11): 3132-3137.

[8]

X. Yan. Early diagnosis of gastric cancer and the establishment of early warning systems. World Chinese Journal of Digestology, 1999, 7(2): 96-97.

[9]

D.X. Cui, L. Zhang, X.J. Yan, et al. A microarray-based gastric carcinoma prewarning system. World J Gastroentero, 2005, 11(9): 1273-1282.

[10]

M. Ferrari, Cancer nanotechnology: Opportunities and challenges. Nature Reviews Cancer, 2005, 5: 161-171.

[11]
J. Conde, G. Doria and P. Baptista, Noble metal nanoparticles applications in cancer. Journal of Drug Delivery, 2012, 2012: Article ID 751075, 12 pages.
[12]

Y.L. Liu, M. Yang, J.P. Zhang, et al. Human induced pluripotent stem cells for tumor targeted delivery of gold nanorods and enhanced photothermal therapy. ACS Nano, 2016, 10: 2375-2385.

[13]

C.X. Yue, C.L. Zhang, G. Alfranca, et al., Near-infrared light triggered ROS-activated theranostic platform based on Ce6-CPT-UCNPs for simultaneous fluorescence imaging and chemo-photodynamic combined therapy. Theranostics, 2016, 6: 456-469.

[14]

J. Ruan, J. Ji, H. Song, et al. Fluorescent magnetic nanoparticle-labeled mesenchymal stem cells for targeted imaging and hyperthermia therapy of in vivo gastric cancer. Nanoscale Res Lett, 2012, 7: 12.

[15]

C.C. Bao, J. Conde, F. Pan, et al., Gold nanoprisms as a hybrid in vivo cancer theranostic platform for in situ photoacoustic imaging, angiography, and localized hyperthermia. Nano Res. 2016, 9: 1043-1056.

Nano Biomedicine and Engineering
Pages 109-111
Cite this article:
Cui D. Gastric Cancer Nanotheranostic Engineering: Gastric Cancer Prewarning and Early Theranostic System. Nano Biomedicine and Engineering, 2016, 8(3): 109-111. https://doi.org/10.5101/nbe.v8i3.p109-111

201

Views

1

Downloads

0

Crossref

0

Scopus

Altmetrics

Published: 21 September 2016
© 2016 Daxiang Cui.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return